Wiboonchutikul Surasak, Manosuthi Weerawat, Likanonsakul Sirirat, Sangsajja Chariya, Kongsanan Paweena, Nitiyanontakij Ravee, Thientong Varaporn, Lerdsamran Hatairat, Puthavathana Pilaipan
Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, 11000 Thailand.
Faculty of Medical Technology, Mahidol University, Bangkok, Thailand.
Antimicrob Resist Infect Control. 2016 May 23;5:21. doi: 10.1186/s13756-016-0120-9. eCollection 2016.
A hospital-associated outbreak of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) was reported. We aimed to assess the effectiveness of infection control measures among healthcare workers (HCWs) who were exposed to a MERS patient and/or his body fluids in our institute.
A descriptive study was conducted among HCWs who worked with a MERS patient in Bamrasnaradura Infectious Diseases Institute, Thailand, between 18 June and 3 July 2015. Contacts were defined as HCWs who worked in the patient's room or with the patient's body fluids. Serum samples from all contacts were collected within 14 days of last contact and one month later. Paired sera were tested for detection of MERS-CoV antibodies by using an indirect ELISA.
Thirty-eight (88.4 %) of 43 identified contacts consented to enroll. The mean (SD) age was 38.1 (11.1) years, and 79 % were females. The median (IQR) cumulative duration of work of HCWs in the patient's room was 35 (20-165) minutes. The median (IQR) cumulative duration of work of HCWs with the patient's blood or body fluids in laboratory was 67.5 (43.7-117.5) minutes. All contacts reported 100 % compliance with hand hygiene, using N95 respirator, performing respirator fit test, wearing gown, gloves, eye protection, and cap during their entire working period. All serum specimens of contacts tested for MERS-CoV antibodies were negative.
We provide evidence of effective infection control practices against MERS-CoV transmission in a healthcare facility. Strict infection control precautions can protect HCWs. The optimal infection control measures for MERS-CoV should be further evaluated.
据报道,某医院发生了中东呼吸综合征冠状病毒(MERS-CoV)医院内暴发疫情。我们旨在评估在我院接触MERS患者和/或其体液的医护人员中感染控制措施的有效性。
对2015年6月18日至7月3日期间在泰国班拉史纳拉杜拉传染病研究所与一名MERS患者共事的医护人员进行了描述性研究。接触者定义为在患者病房工作或接触患者体液的医护人员。在最后一次接触后的14天内及1个月后收集所有接触者的血清样本。采用间接ELISA法检测配对血清中的MERS-CoV抗体。
43名已识别的接触者中有38名(88.4%)同意参与研究。平均(标准差)年龄为38.1(11.1)岁,79%为女性。医护人员在患者病房工作的累计时长中位数(四分位间距)为35(20 - 165)分钟。医护人员在实验室处理患者血液或体液的累计时长中位数(四分位间距)为67.5(43.7 - 117.5)分钟。所有接触者均报告在整个工作期间100%遵守手部卫生规范、使用N95口罩、进行口罩适合性检测、穿隔离衣、戴手套、戴护目镜和帽子。所有接触者检测MERS-CoV抗体的血清标本均为阴性。
我们提供了医疗机构针对MERS-CoV传播采取有效感染控制措施的证据。严格的感染控制预防措施可保护医护人员。MERS-CoV的最佳感染控制措施应进一步评估。